Skip to main content

Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

Roundup Deal: Plaintiffs Raise Concerns; Judge Casts Doubt

Introduction

On Thursday, U.S. District Judge Vince Chhabria, overseeing the Roundup multidistrict litigation docket, indicated that he might lift the stay on litigation after hearing concerns from plaintiffs' attorneys over the uncertainty of the more than $10 billion deal.

In June, the German chemical and pharmaceutical giant, Bayer, indicated that it would pay more than $10 billion to settle about 75% of the lawsuits claiming that its herbicide Roundup was the cause of non-Hodgkin’s lymphoma. Following the announcement of the deal, which is managed by mediator Kenneth Feinberg, Judge Chhabria halted the multidistrict litigation for the settlement process.

In July, Judge Chhabria had raised concerns over one part of the deal, which includes a plan for handling future claims brought by the consumers who develop non-Hodgkin’s lymphoma, after using the weedkiller. He indicated that he is skeptical of the propriety and fairness of the proposed settlement, and is tentatively inclined to deny the motion.

In the recent hearing, Judge Chhabria stated that he received several confidential letters alleging the manufacturer of reneging on its deal with the plaintiffs. After hearing arguments from both parties, he concluded that he would not lift the stay expressing his confidence in Feinberg’s ability to reach a resolution in 30 days. But he also noted that the parties should also start reworking on getting the litigation back on track as he won't extend the stay any further. The parties have been asked to be prepared by the next case management conference that is scheduled for September 24.

Roundup, one of the most commonly and widely used weedkillers, contains Glyphosate as one of its main ingredients. Glyphosate is a systemic and broad-spectrum herbicide that was patented by a U.S. company, Monsanto, in 1970. Bayer acquired Monsanto on June 7, 2018.

Currently, Bayer is facing more than 125,000 Roundup lawsuits, and the company has acknowledged the filing of 52,500 lawsuits. The lawsuits are consolidated under MDL No. 2741 in the U.S. District Court for the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Pesticide Shield Bill Faces Long Odds in Missouri Senate

Categories: General

Legislation aimed at making it harder to sue pesticide manufacturers over cancer claims is facing a critical deadline, with an unusual coalition of opponents striving to stall its progress.

Philips Sues CPAP Cleaner SoClean to Share Settlement Costs

Categories: Settlements

Philips has filed a lawsuit against SoClean, a company that manufactures ozone-based cleaning systems…

NJ Pharma Settles: Cash, Narcan for Delaware

Categories: Settlements

Amneal Pharmaceuticals, a New Jersey-based drug manufacturer, has reached a settlement agreement with Delaware and other states over its involvement in the…

Our Legal Drafting Services    
start @ $25 per hour.